March 27, 2025

Jen Butler, Chief Commercial Officer at Pleio, discusses the effectiveness of peer-to-patient outreach when starting specialty medications.

March 26, 2025

“Pleio’s GoodStarters are already highly trained, empathetic peers who connect with patients in a way that truly matters. OLLIE takes that to the next level — it’s human connection, amplified — technology that makes our people even better at what they do best.” – Michael Oleksiw, CEO at Pleio

March 26, 2025

Jen Butler, Chief Commercial Officer at Pleio, discusses how the company’s GoodStart programs help patients navigate specialty medication onboarding.

March 26, 2025

HIT Consultant covers the launch of OLLIE, an AI-powered solution that deepens patient engagement from the start of treatment. The tool empowers individuals early on and builds a strong foundation for long-term behavioral treatment success.

March 26, 2025

“While technology plays a crucial role, human connection remains at the heart of meaningful support. OLLIE listens and analyzes patient conversations in order to better understand the patient experience. These insights are then used to create, deliver, and report upon our proven GoodStart programs, ensuring every interaction builds trust, confidence, and support for patients.” – Martin Robert, Chief Product Officer at Pleio 

March 11, 2025

Jennifer Butler, Chief Commercial Officer of Pleio, discusses misinformation’s threat to public health, where patients are turning for trustworthy health information, the industry’s pivot to peer-to-patient strategies to educate patients, and more.

FOR MEDIA INQUIRIES PLEASE EMAIL media@pleio.com.

WE PUT PRIVACY FIRST. GOODSTART® IS A FULLY TESTED, HIGHLY RELIABLE, TCPA, SOC 2 TYPE 2 CERTIFIED, AND HIPAA COMPLIANT MEDICATION SUPPORT PROGRAM.

Patient data is strictly used to support patients to take medications as prescribed by their healthcare professional.

CONTACT   |   PRIVACY   |  CAREERS

© 2025 Pleio, Inc All rights reserved.